Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

OptimizeRx Corporation (OPRX)

NCM · Health Information Services

$6.34-0.04 (-0.63%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$119.0M
P/E (TTM)
17.61
EPS
$0.36
Div Yield
—
52W Range
$4.54–$22.25
Beta
1.08

Company overview

Next earnings: 2026-08-06(9d)

OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.

Peers in Health Information Services

All in industry →

Recent press releases

April 2026

3 months ago8-KHealthcare

OptimizeRx Appoints Mary Varghese Presti to Board

OPRXOptimizeRx Corp

# 🧾 What This Document Is This is an **8-K filing** with an attached **press release**. Companies use 8-Ks to announce major events to investors. Here, OptimizeRx is formally announcing a key leadership change: a new, independent member has been added to its Board of Directors. This is part of a pl

Read summaryView on SEC EDGAR
1 recent filing shown in the timeline above. View all SEC filings →

OptimizeRx Corporation has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
1,508,303 sh0.0%
1,194,711 sh+0.6%
1,136,933 sh+7.3%
25,224 sh-91.8%
673,920 sh-0.1%
682,030 sh+0.7%
112,867 sh-64.8%
582,585 sh-1.4%

People at OptimizeRx Corporation

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
$146.0K
NI -$2.2M
06/25
$27.0K
NI $1.5M
09/25
$26.1M
NI $779.0K
RevenueNI = Net Income
EPS trend (diluted)
Latest: $0.04
Prior: $0.08
Revenue sparkline